chrisvoncsefalvay/vaers-outcomes huggingface dataset:
while reconstituting Shingrix, liquid squirted into eyes; while reconstituting Shingrix, liquid squirted into eyes; This case was reported by a nurse via call center representative and described the occurrence of occupational exposure while preparing product for administration in a 35-year-old female patient who received Herpes zoster (Shingrix) (batch number GC744, expiry date 28th August 2023) for prophylaxis.   On 14th August 2022, the patient received Shingrix. On 14th August 2022, unknown after receiving Shingrix, the patient experienced occupational exposure while preparing product for administration and exposure via eye contact. On an unknown date, the outcome of the occupational exposure while preparing product for administration and exposure via eye contact were unknown.   Additional Information: GSK Receipt Date: 09-AUG-2022 Reporter's comments: The nurse reported that while she was reconstituting Shingrix some of the liquid squirted into her eyes. She washed her eye with plenty of water. She was looking for information about any possible side effect. This happened on 14th August 2022. The reporter consented to follow-up. Additional supportive information: Reconstituted Shingrix was accidentally splashed into nurse' eye, which led to occupational exposure while preparing product for administration and exposure via eye contact.
More than 36 days without receiving the second dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days without receiving the second dose.) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days without receiving the second dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days without receiving the second dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided No treatment was reported
We had our first Pfizer covid shots in March. The morning after my wife developed a blood blister in her mouth. Three weeks later in April we had the second shots. Again my wife developed a blood blister in her mouth the very next day. Since then she has had reoccurring blood blisters accompanied by headaches almost weekly.
This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced BACK PAIN (pain in back). At the time of the report, BACK PAIN (pain in back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of back pain, a causal relationship cannot be excluded.
This case was reported by a consumer via call center representative and described the occurrence of muscle spasm in a 79-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included back surgery (had some time ago before the date of reporting and her back has not bothered her in 1.5 years). Previously administered products included Influenza vaccine Quadrivalent unspecified season (received on an unknown date, refer case ID US2018GSK162474). Concurrent medical conditions included back disorder. On 27th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In August 2018, less than a week after receiving SHINGRIX, the patient experienced muscle spasm. On 27th August 2018, the patient experienced headache and pain in arm. On 28th August 2018, the patient experienced localized erythema, local swelling and localized feeling of warmth. On an unknown date, the outcome of the muscle spasm, localized erythema, local swelling, headache and pain in arm were not recovered/not resolved and the outcome of the localized feeling of warmth was unknown. The reporter considered the muscle spasm to be possibly related to SHINGRIX. It was unknown if the reporter considered the localized erythema, local swelling, localized feeling of warmth, headache and pain in arm to be related to SHINGRIX. Additional details were provided as follows: In the evening after receiving SHINGRIX, the patient started experiencing a headache and pain in her left arm. The patient used ice on her arm to help with the pain. On 28th August 2018, Tuesday, 1 days after receiving SHINGRIX, the patient noticed redness and swelling on her left arm and that her left arm felt hot. The pain, redness and swelling that the patient experienced following the SHINGRIX vaccine was located below the injection site. In August 2018, less than a week after vaccination, the patient experienced muscle spasms in her lower left leg. The patient felt the spasms from below the knee down to the foot. The patient stated that it was possible that the spasms could be related to the vaccine but could also possibly be related to her back problems.
My arm was painful at the injection site for several days but Tylenol and ice/warm compress alleviated that. Since then, 2 large, red, round welts - one at the injection site, and a larger one below it, have come up and are getting bigger over the week since.  Pictures available
Information has been received from a physician concerning a 28 year old female who in 1998 was vaccinated with varicella vaccine. The physician reported that several titers had been done, including one recently, and none of the lab evaluations had shown seroconversion. The pt had sought medical attention for her experience. Additional info has been requested.
Arm started itching; it was really hard at injection site; it was really hot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), INJECTION SITE REACTION (it was really hard at injection site) and INJECTION SITE WARMTH (it was really hot at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (Patient had breast cancer on left side and right side patient also has lymph node after surgery.) Concomitant products included EXEMESTANE for Breast cancer, ATORVASTATIN and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Mar-2021, the patient experienced PRURITUS (Arm started itching), INJECTION SITE REACTION (it was really hard at injection site) and INJECTION SITE WARMTH (it was really hot at injection site).    Treatment included Tylenol(Acetaminophen) was noted.  At the time of the report, PRURITUS (Arm started itching), INJECTION SITE REACTION (it was really hard at injection site) and INJECTION SITE WARMTH (it was really hot at injection site) outcome were unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Woke up morning after 2nd dose of COVID-19 vaccine with noticeable left armpit swelling (noticed while applying my deodorant for the day).  Swelling was the size of large lemon.  Smaller amount of swelling noticed in right armpit, also.  Vaccinations had both been done in my LEFT arm and greater swelling was in left armpit.  Had fever, chills and headache this same day requiring me to take round the clock doses of Tylenol.  By the following day, fever and chills were gone but swelling of armpit still present.  Swelling is slowly diminishing but still present by day 3, as I send this notification.
OCTOBER 1---5:00 pm: too tired to stay awake, 11:00 splitting headache and body discomfort OCTOBER 2---7:00am woke to terrible headache, 103 degree fever, light sensitivity and body aches, left armpit swelling continued until the size of a tennis ball.  It appeared and felt like it was full of water.  Lymph node was sensitive, very painful and movement of my arm sent stabs of pain into my body. Rash around injection site approx 9 inches from top to bottom began to show in morning.  Increased through out day  and became swollen and hot.  Took more ibuprofen than advised and fever ranged from 98.9 to 102.5 depending on when I had taken ibuprofen.  OCTOBER 3-----Felt a bit better. Still maintained 99 degree fever and headache.  lympnode and rash stayed the same size.  OCTOBER 4----Woke to a pounding stabbing headache and 100 fever.  Two hours after taking ibuprofen headache decreased. Lymphnode swelling had gone down about 80% Rash was no longer swollen though still hot.   Note that all these symptoms I had after taking Covid shot #2.  Tho they were much worse with the Covid shot.  The symptoms are so similar to Covid Vaccine I wondered if they gave me wrong injection.  I cannot get the dr to tell me what brand the vaccine was so I can see if it was the one I was given .  The vial the nurse drew from was purple and white.
I received the second Pfizer covid vaccine on a Sunday and the following Tuesday I got a migraine. I thought this was just a coincidence and therefore, did report it. However, after receiving the booster dose on 10/24 which was a Sunday, I then got a migraine on the following Tuesday. So I don't think this is a coincidence.
Medication error, Spoke with healthcare professional- Advised NOT to repeat 5-11 dose to complete series. To give adolescent dose Pfizer for 12 y.o. for 2nd dose to complete series on return date of 12/10/21. Parent notified, aprop process completed per policy by  reporting RN.
I was sensitive to noise; felt weak; 4 hours after my vaccine I felt an intense pain in my left arm on injection site; Chills; Mild body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERACUSIS (I was sensitive to noise), ASTHENIA (felt weak), INJECTION SITE PAIN (4 hours after my vaccine I felt an intense pain in my left arm on injection site), CHILLS (Chills) and MYALGIA (Mild body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Drug allergy (unspecified drug).    On 14-Jul-2021 at 3:45 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2021 at 8:30 PM, the patient experienced HYPERACUSIS (I was sensitive to noise), ASTHENIA (felt weak), INJECTION SITE PAIN (4 hours after my vaccine I felt an intense pain in my left arm on injection site), CHILLS (Chills) and MYALGIA (Mild body aches). In July 2021, HYPERACUSIS (I was sensitive to noise), ASTHENIA (felt weak), INJECTION SITE PAIN (4 hours after my vaccine I felt an intense pain in my left arm on injection site), CHILLS (Chills) and MYALGIA (Mild body aches) had resolved.            No concomitant medication was reported.  It was reported that 4 hours after vaccination patient felt an intense pain in left arm on injection site. It made it difficult to simply put on deodorant or pick up a cup. Had mild body aches and chills that lasted 2 days on and off. Patient was sensitive to noise and felt weak. The symptoms all together lasted for about 3 days.  On 10-Aug-2023, Patient received paxlovid 150(X2) for treatment of COVID-19  No treatment was received.
This spontaneous report was received from a physician concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with 0.5 milliliter (ml) of PNEUMOVAX 23 (lot number and expiry date unspecified), intramuscularly. No concomitant medications were reported. Approximately on an unknown date in 1998 (reported as 10-15 years ago), the patient experienced severe allergic reaction. The patient did not specify if it was life threatening or if any emergency measures were used. The patient sought an unspecified medical attention. An unspecified treatment was given to the patient. It was unspecified if any lab tests were performed. The outcome of severe allergic reaction was unknown. The relatedness for severe allergic reaction was unknown for PNEUMOVAX 23. This is one of the two reports from the same source. Additional information is not expected.
Violent tremors or chills in the middle of the night for half an hour, followed by a burning electric feeling in my muscles. Not able to sleep afterwards. Woke up and muscles in body are very tight and tense.
We had been quarantined since 10/31/2022 due to my husband?s COVID diagnosis. Patient had a breakthrough case of COVID with initial positive test on 11/04/2022. Patient had severe vomiting and diarrhea that started that night. The diarrhea was intermittent throughout the following weeks but the vomiting did not fully subside until November 25, 2022. On November 15th the vomiting was for 12 hours straight. The other days it was once a night around 7-8 pm. He would vomit up all of his daily food intake. His stomach would hurt and be distended until he vomited, which is out of the ordinary for him. The contents of his stomach would still contain items he ate for breakfast 12 hours prior. Patient was seen by his pediatrician on 11/18/2022 for this condition.
English: ADMINISTRATION ERROR  A 12-year-old female patient receives the Pfizer booster dose (0.3mL) without complying with the established guidelines, since she was supposed to receive said dose on February 9, 2022.
Arm soreness; Back aches; Headache; This is a spontaneous report from a non-contactable nurse, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 30Apr2021 at 15:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced arm soreness, backaches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events arm soreness, backaches, and headache were recovering at the time of the report.  No follow-up attempts are possible. No further information is expected.
Patient reported onset of paresthesia's in fingers and toes in late April, about 1-2 weeks after her vaccination.  They improved significantly in July and have been stable since . Neurologic exam is normal.  I'm ordering MRI brain and C spine to r/o transverse myelitis or MS.   We don't plan any treatment unless they worsen again.
This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6205) via an unspecified route of administration administered in right arm on 12Mar2021 at 11:30 (at 52 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There was no relevant medical history or concomitant medications. The patient had no known allergies. The patient did not have COVID-19 prior to vaccination. The patient was not tested for COVID-19 post vaccination. The patient reported that the next day of the vaccination, patient started seeing floaters in left eye, which was non-serious on 13Mar2021 at 08:00. No treatment received for the event. Outcome of the event was not recovered. No follow-up attempts are possible; no further information is expected.
Dizziness, headache, nausea, vomiting, feeling that jaws were locked.  Unable to walk. Hot, clammy, sweaty.  It lasted for about three hours and gradually improved. Headache persisted for about three days. Patient was checked by paramedics (at home) who stated that all values appeared normal.  Offered to transport to hospital.  Patient refused.  Paramedics said that patient had no indications of shock. Incident was reported to patient?s primary care physician.
swelling got worse; Swelling in right foot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in right foot) and CONDITION AGGRAVATED (swelling got worse) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in right foot). On an unknown date, the patient experienced CONDITION AGGRAVATED (swelling got worse). At the time of the report, PERIPHERAL SWELLING (Swelling in right foot) and CONDITION AGGRAVATED (swelling got worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided
A report was received from a healthcare professional on 10/08/2003 concerning a 41 year old male vaccinee who experienced shaking, chills, fever and memory loss on 10/07/2003 after receiving 0.5ml Fluvirin on 10/06/2003. On 10/06/2003, in the afternoon, the vaccinee received Fluvirin 0.5ml intramuscularly in his left deltoid muscle.  On the morning of 10/07/2003, the vaccinee developed shaking, chills and fever.  Furthermore, the vaccinee did not recall what occurred that morning including conversations with his family members.  All of the symptoms have completely self-resolved within 12 hours of onset. There was insufficient information to determin the reporter's causality assessment. Update 1, 11/03/2003: Further information received from a healthcare professional on 11/03/2003 indicated that the vaccinee woke at 05:00 hours on 10/07/2003 after receiving Fluvirin 12-13 hours previously.  He developed uncontrollable shaking chills, myalgias and he was hallucinating.  The vaccinee stated that he did not recognize his own father.  The hallucinations resolved on 10/07/2003 and the shaking chills, myalgias and fever resolved on 10/08/2003.  The vaccinee was advised not to take the Flu vaccine again. The reporter has assessed the relationship of the vaccine to the shaking chills, hallucinations, myalgias and fever as probable. No follow up pending, all information received.
10.5 x 12 cm left arm redness warmth & pain, not immediately, but following Shingrix vaccine
Information has been received from a nurse practitioner referring to 4 year old male patient with dermatitis contact and no known drug allergy. The patient had common cold at time of vaccination. Concomitant therapies included (Oka/Merck) VARIVAX and KINRIX. On 03-JUN-2016 at 10:41, the patient was vaccinated with (wistar ra 27-3) M-M-R II lot # L042267 dose 2, subcutaneously in the left thigh. The vaccine was properly stored at 53.2 F for 9 hours and 25 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effect was reported. This is one of several reports received rom the same reporter. Additional information has been requested. Information
rash on left shoulder  itching at injection site itching down arm itching at palm of left hand that lasted 6 days  Swollen lymph nodes on left side of body that are now painful
Info has been received from a pharmacist concerning her 15 month old son with no allergies or medical history who on 11/29/05, was vaccinated with a dose of MMRII. There was no illness at the time of vaccination. On 12/9/05, the pt experienced a rash on his cheeks, abdomen, chest, and back. The rash was slightly raised and stated on the pt's face and was improving in that location. The rash remained on the other areas of the body. The pt was also experiencing sleep disturbance, decreased appetite, and fatigue. A product quality complaint was not involved. Additional info has been received from a physician who reported that no adverse vaccine reaction was observed. The pt had a low-grade fever and and rash nine days after vaccination on 12/8/05, which resolved one to two days later. The physician told the pt's family that the low-grade fever and rash at the injection site were not unusual and not adverse. No diagnostic/lab tests were performed. There  was no adverse events following prior vaccination.
Developed hive like rash without resp distress. Tx: oral BENADRYL PRN.
I have had been suffering from fatigue.  I actually caught covid for the first time in mid December 2020.  I recieved my first vaccination on 2/24/21.  I recieved my booster on 3/18/21.  I recieve my 3rd booster on 1/6/22.  I caught covid again around 1/10/22.  THrough this whole cycle I am experiencing lost of interest in energy.  It seems to continually get more so.  I have been to the Dr (the one listed on this survery) and did a Low T test as well as blood panel.  I am usually very energetic, always busy doing something.  Anymore I have little interest in doing things and really have to force myself to stay active.  When I am active and stop (Ie sit down on couch) i fall asleep.  This has seemed to line up with Covid and the vaccinations.  Maybe this is not the cause but line up pretty well.  I plan to visit the Dr again soon to see what other thoughts he may have to my fatigue.  I am also have a lot of lower GI stuff going on.  Not sure if that is related as well...
Fever started 1/7/20 and was 101 degrees.  Was warm to the touch when she woke up on 1/8/20 but after her morning nap she woke up shaking uncontrollably and had a fever of 105 degrees.  I called the nurse at pediatrics and she said to alternate giving her tylenol and ibuprofen.  I did and it brought her fever down to 101-102 degrees.  Had fever until 1/9/20 when it finally went down.  Then she started to get a rash which started in her trunk/torso area.  It looked exactly like Measles.  She had the rash until it slowly started to go away on 1/14/20.  Every night that she had the fever and rash she woke up screaming uncontrollably for at least an hour every night.  Was in severe pain, didn't want to be held because her body hurt but also didn't want to be set down.  When I brought her into the doctor they denied that it could even remotely be from the vaccine, even though the rash looked exactly like the Measles.
w/in 5" p/inj c/o weakness, blurry vision, dizziness, everything is moving slowly, & swollen tongue;P84, BP 110/70, t98.9 TM finger stick 100;sl pale, slurred speech, walking slowly, dazed;seen @ clinic x2hr dx atypical HBV rxn;
HPI: 85 y.o. female with a PMH of osteopenia, DM, HLD, HTN, BPPV, CVA on plavix, anemia presents with fever, myalgias, cough x 9 days. Pt states her son and sister were also sick with similar symptoms. She is COVID vaccinated. She endorses white sputum production. Denies any loss of appetite. States has felt decreased energy. Temperature was highest earlier today at 101.7. Pt states she was visiting her husband, who is currently admitted for DKA, where staff noticed that she didn't look well. Her RA O2 was noted to be at 78%, she was placed on HFNC and sent to the ED.